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Abstract
ARAP3, a GTPase activating protein for Rho and Arf family GTPases, is one of many PI3K
effectors. Here we investigate the regulatory input of PI3K upstream of ARAP3, by analysing
neutrophils from an ARAP3 PH domain point mutation knock-in mouse (R302, 303A), in which
ARAP3 is uncoupled from activation by PI3K. ARAP3 PH domain point mutant neutrophils are
characterised by disturbed responses linked to stimulation by either integrin ligands or
immobilised immune complexes. These cells exhibit increased β2 integrin inside-out signalling
(binding affinity and avidity), and our work suggests the disturbed responses to immobilised
immune complexes are secondary to this. In vitro, neutrophil chemotaxis is affected in the mutant.
In vivo, ARAP3 PH domain point mutant bone marrow chimeras exhibit reduced neutrophil
recruitment to the peritoneum on induction of sterile peritonitis and also reduced inflammation in
a model for rheumatoid arthritis. The present work suggests a dramatic regulatory input of PI3K
into the regulation of β2 integrin activity, and processes dependent on this, by signalling through
its effector ARAP3.
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Introduction
Neutrophils are highly specialised cells that form part of the innate immune system (1).
These terminally differentiated, short-lived cells are continuously being generated in the
bone marrow. Mature neutrophils reside in a quiescent state in the blood stream. On
stimulation they follow a well-defined activation pathway which includes rolling along the
vessel wall, followed by weak and then firm adhesion. Neutrophils finally extravasate and
chemotax to sites of damage and/or infection, to phagocytose pathogens. Insufficient
neutrophil activation leaves individuals susceptible to recurrent infections, as exemplified in
leukocyte adhesion deficiency patients, where β2 integrin function is affected. On the flip
side, neutrophils contribute to inflammation by producing reactive oxygen species (ROS)
and cytotoxic enzymes. IgG-coated microorganisms drive the activation of neutrophil Fcγ
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receptors (FcγR), triggering neutrophil activation, normally at a site of infection.
Immobilised immune complexes formed by autoantibodies reacting with their (host)
antigens also trigger FcγR mediated neutrophil activation targeted against host tissue,
leading to exacerbated autoimmune inflammatory responses. Neutrophil activity therefore
needs to be tightly controlled to ensure an adequate innate immune response, whilst
avoiding exaggerated inflammatory responses. On a molecular level, this control is exerted
by many regulators, including agonist activated (class I) phosphoinositide 3-OH kinases
(PI3Ks) and their effectors.
Agonist-activated PI3Ks are heterodimeric proteins that are activated downstream of
tyrosine kinase coupled receptors (class IA) and G protein coupled receptors (class IB),
respectively, as well as Ras. PI3Ks are responsible for the generation of the lipid second
messengers phosphatidylinositol-(3,4,5)-trisphosphate [PtdIns(3,4,5)P3] and PtdIns(3,4)P2 in
the plasma membrane (2). This drives the activation, mediated often at least in part by
recruitment to the plasma membrane, of PI3K effectors. Although most attention has been
placed on Akt / PKB signalling downstream of PI3K, there are also many other PI3K
effectors; it is estimated that most cell types express in excess of 25 different PI3K effectors,
which all mediate downstream effects. A large number of PI3K effectors isolated to date are
regulators of small GTPases.
ARAP3 is a PI3K effector that was identified from neutrophils in a screen for
PtdIns(3,4,5)P3 binding proteins (3). ARAP3 is a GTPase activating protein (GAP) for the
small GTPases RhoA and Arf6, and it is regulated by PI3K and Rap-GTP. PtdIns(3,4,5)P3
regulates ARAP3 catalytically as an Arf GAP and causes ARAP3’s recruitment to the
plasma membrane, thereby bringing it into vicinity of its substrates and of Rap-GTP, which
activates ARAP3 as a Rho GAP (3, 4). We previously showed that ARAP3 is a regulator of
integrin-dependent neutrophil functions (5).
To understand the regulatory input of PI3K into ARAP3 in the neutrophil, we here report the
analysis of neutrophils from knock-in mice in which ARAP3 carries a double point mutation
in the most N-terminal PH domain (R302, 303A). This double point mutation renders
ARAP3 unable to interact with, and be activated by PtdIns(3,4,5)P3 (3, 6). For ease of
reading, we refer here to this PH domain point mutation knock-in as PH*. Like ARAP3-
deficient neutrophils, Arap3PH*/PH* cells exhibited perturbed responses on adhesion-
dependent stimulation, and showed increased β2 integrin affinity and clustering.
Arap3PH*/PH* neutrophils were also hyperactive when plated onto immobilised immune
complexes, but not on cross-linking FcγR in solution. In vitro chemotaxis assays showed a
directionality defect of Arap3PH*/PH* neutrophils, whilst in vivo, Arap3PH*/PH* neutrophils
were characterised by reduced recruitment to the peritoneum after induction of sterile
peritonitis and by subtly reduced inflammation in an autoantibody-induced arthritis model.
Materials and Methods
Unless otherwise stated, materials were obtained from Sigma, Dorset, UK.
Antibodies
Mouse anti-BSA (clone BSA-33) was from Sigma (Dorset, UK); rat anti-FcγRII/III
(CD16/32; clone 93) was from eBioscience (Hatfield, UK); hamster anti-FcγRIV (blocking
antibody; clone 9E9) has been described (7) and was a kind gift from Falk Nimmerjahn
(Erlangen University, Germany). Sheep anti-ARAP3 has been described (3) and mouse anti
β-COP was a gift from Nick Ktistakis. Mouse anti RhoA, anti Rap1 and anti Arf6 were from
Santa Cruz Biotechnology (Santa Cruz, California, USA). Rabbit anti phospho-Akt, anti
phospho-p38 and anti phospho myosin light chain antibodies were from Cell Signaling
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Technology / New England Biolabs (Hitchin, UK). Goat anti-mouse HRP conjugate was
obtained from BioRad (Hemel Hempstead, UK), and goat anti-rabbit and anti-sheep were
from Santa Cruz Biotechnology. Alexafluor-conjugated, highly cross-absorbed secondary
antibodies were from BD Invitrogen - Molecular probes (Paisley, UK). Goat anti-rat F(ab’)2
was from Jackson Immuno Research (via Stratech, Newmarket, UK); FITC-conjugated
mouse anti-hamster IgG was from BD Pharmingen (San Diego, California, USA).
Fluorescently-conjugated anti-GR1, anti-LFA1 and anti-Mac1 as well as all isotype controls
were obtained from eBioscience.
Arap3PH* mouse model
Generation of the Arap3PH* mouse has been previously described. Experiments performed
for this work were carried out with mice derived from the BB10 clone, which produces rare
homozygous mutants (8). Since the frequency of Arap3PH*/PH* mice was very low, we
generated cohorts of Arap3PH*/PH* and wild-type bone marrow chimeras. In vitro
experiments were carried out with matched wild-type and Arap3PH*/PH* mice, and in
parallel with bone marrow chimeras (using chimeras originating from different donors for
duplicate experiments). The results obtained in this fashion were pooled. Since ARAP3 is
known to be expressed in the murine vasculature, in vivo experiments were only carried out
with bone marrow chimeras, ensuring only neutrophil-dependent defects were assessed.
Animal work carried out at Babraham Institute was approved by United Kingdom Home
Office Project licenses PPL08/175 and PPL80/2335. Experiments carried out at
Semmelweiss University were approved by the Semmelweis University Animal
Experimentation Review Board.
Reconstitutions
Cohorts of C57Bl/6 mice were lethally irradiated and subsequently reconstituted by tail vein
injection with 4 × 106 bone marrow cells from Arap3PH*/PH* mice or from sex and age
matched wild-type controls. Complete reconstitution of the hematopoietic system was
confirmed by flow cytometry.
Neutrophil purification
Neutrophils were isolated from bone marrows of 12 to 14 week old sex- and age-matched
mice using discontinuous Percoll gradients (GE Healthcare Amersham, Uppsala, Sweden) as
described (9, 10), using endotoxin-free reagents throughout. Chimeric mice were used six to
eight weeks after reconstitution.
Analysis of peripheral blood
Tail vein blood was collected in EDTA-coated microvettes (Sarstedt, Nümbrecht, Germany)
for analysis using a Vetabc animal blood cell counter.
Immobilisation of adhesive proteins and immune complexes
Sheep fibrinogen (150μg/ml) or polyRGD (20μg/ml) were adsorbed onto tissue culture
grade plastics overnight at 4°C (fibrinogen) or for 3 hours at room temperature (polyRGD).
Surfaces were washed prior to performing any assays. For immune complexes, dishes were
coated overnight at 4°C with essentially endotoxin and fatty acid free BSA in PBS (100μg/
ml), blocked with 1% fat free milk in PBS for 1 hour, and incubated with mouse anti-BSA
(1:10000) for 1 hour at room temperature.
FcγR cross-linking
FcγR cross-linking was performed as described elsewhere (11) using rat anti-FcγRII/III and
goat anti-rat F(ab’)2.
Gambardella et al. Page 3
J Immunol. Author manuscript; available in PMC 2013 July 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
ROS production assays
ROS production was measured by chemiluminescence employing a luminol-based assay in
polystyrene 96-well plates (Berthold Technologies, Bad Wildbad, Germany) as described
(12). 5×105 cells were incubated with luminol (150μM) and HRP (18.75 U/ml) for 10
minutes at 37°C. Where indicated, neutrophils were added manually to wells pre-coated
with fibrinogen or polyRGD with or without murine TNFα (20ng/ml, R&D systems) or to
immobilised immune complexes. For soluble agonist assays with fMLF (10μM final
concentration), cells were primed for 1hr at 37°C in the absence (mock) or presence of
mouse TNFα (1000U/ml) and GM-CSF (100ng/ml). For all assays, measurements were
started immediately and light emission was recorded. Data output is relative light units per
second (RLU/sec) or total RLU integrated over indicated measured periods of time.
Chemotaxis assays
For micropipette assays, neutrophils were resuspended in HBSS, 15mM Hepes pH 7.4,
0.05% BSA, and allowed to attach to a glass coverslip. Cells were stimulated at 37°C with a
point source of fMLF delivered from a microinjection pipette (femtotip, Eppendorf,
Cambridge, UK) using 50 mbar pressure as described (5) and monitored by time-lapse
imaging for 30 minutes using an inverted Zeiss axiovert microscope (Welwynn Garden City,
UK) and Axiovision software. Dunn chamber chemotaxis assays were carried out as
described (10, 13), using fMLF or MIP2 as chemoattractant. Cells were tracked using the
‘manual tracking’ and tracks were analysed using the ‘Chemotaxis Tool’ plug-ins (Ibidi,
Planegg, Germany) into Image J.
MAPK, Erk and PKB activation assays
These assays were carried out with cells plated onto polyRGD, BSA-antiBSA immune
complex coated, or hiFCS-blocked dishes essentially as described (14) or cells were lysed at
indicated timepoints after FcγRII/III cross-linking as described (11).
Degranulation assay
Release of gelatinase granules after plating onto a fibrinogen- or immune complex coated
surface, or as induced by stimulation with fMLF and cytochalasin B was detected by
zymography as described (15).
Analysis of β2 integrins
Surface integrins were visualized by FACS analysis of stained cell populations. Bone
marrow cells were co-stained with anti-GR1 FITC and anti-integrin Cy5. GR1high cells
were gated and analysed for level of integrin expression. Integrin clustering was analysed by
confocal microscopy of unstimulated, stained cells that were kept in solution at the time of
assaying and that were allowed to settle onto electrostatic slides (superfrost +; VWR,
Lutterworth, UK) after fixation. To measure integrin binding affinity, unstimulated cells
were allowed to bind to ICAM1-Fc chimera (R&D systems, Abingdon, UK) in solution;
after fixation, bound ICAM1-Fc was stained using a highly cross-absorbed alexafluor-
conjugated anti-human Fc antibody, and cells were allowed to settle onto electrostatic slides.
Bound ICAM1 was measured using quantitative immunofluorescence as described (5).
K/BxN serum transfer arthritis model
The K/BxN serum transfer model was performed as described (16) using lethally irradiated
recipients reconstituted with Arap3PH* or matched control bone marrows. Mice were
injected with 150μl of arthritogenic or control serum and ankle thickness and clinical scores
were measured for the following 14 days. Sample preparation for histology was as described
(17).
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Small GTPase activity assays
RhoA-GTP was determined by G-LISA assay (Cytoskeleton Inc, Denver, Colorado, USA);
Arf6-GTP and Rap1-GTP were identified by pull-down assay as described (5).
Results
ARAP3 is a PI3K and Rap regulated dual Rho and Arf GAP that was isolated in a screen for
PtdIns(3,4,5)P3 binding proteins from neutrophils. PtdIns(3,4,5)P3 binds ARAP3 in a
pleckstrin homology (PH) domain dependent fashion, and regulates ARAP3 catalytically as
well as causing its plasma membrane recruitment. ARAP3 can be uncoupled from activation
by PI3K by insertion of a double point mutation in its most N-terminal PH domain (3, 6).
We previously showed that introducing this PH domain mutation (R302, 303A; here termed
PH*) into ARAP3 led to embryonic lethality (8). A small number of homozygous mutant
pups from Arap3+/PH* intercrosses from mice derived from one of two independently
targeted ES cell clones were viable and fertile [(8); Table 1]. Arap3PH*/PH* knock-ins which
survived to adulthood were healthy and fertile. We analysed their neutrophils and those
isolated from lethally irradiated recipient mice that had been reconstituted with bone marrow
cells from Arap3PH*/PH* or matched wild-type control mice, to elucidate the regulatory input
of PI3K into ARAP3 in the neutrophil.
Expression of ARAP3 protein was not affected by the presence of the PH domain point
mutation in heterozygous or homozygous mutants (Fig. 1A). We detected no differences in
expression of the ARAP family members ARAP1 and ARAP2 (not shown). Peripheral
blood cell counts from chimeric mice reconstituted with control and Arap3PH*/PH* bone
marrow cells were very similar (Fig. 1B).
Adhesion-dependent events are upregulated in Arap3PH*/PH* neutrophils
Neutrophils produce ROS in a well-characterised manner in response to a variety of stimuli.
This allows the analysis of the machinery required for ROS production, and also of
signalling pathways required for ROS production after a particular stimulus. ROS
production of purified wild-type control and Arap3PH*/PH* neutrophils on stimulation with
the soluble agonist fMLF (Fig. 2A,D), or with the non-physiological soluble stimulus PMA
(not shown), was very similar, indicating ARAP3 is not required downstream of PI3K for
ROS generation per se. However, when we assayed ROS production after plating
neutrophils onto the physiological Mac1 ligand fibrinogen or onto the synthetic multivalent
integrin ligand polyRGD, ROS production was significantly increased in Arap3PH*/PH*
compared to the control neutrophils (Fig 2. B,C,E,F). For stimulation by fibrinogen
neutrophils require a co-stimulatory event, for example by a pro-inflammatory cytokine like
TNFα (18). Interestingly, plating Arap3PH*/PH* onto fibrinogen caused significantly
increased ROS production even in the absence of any co-stimulation (Fig. 2B,E), suggesting
that the knock-in cells were present in a pre-activated state.
We investigated whether signalling events known to lie downstream of β2 integrin ligation
(outside-in signalling) were affected by uncoupling ARAP3 from PI3K. We assessed
adhesion-dependent activation of PKB (also known as Akt) and p38 MAPK using phospho-
specific antibodies and observed significantly enhanced PKB and p38 phosphorylation in
Arap3PH*/PH* cells that had been plated onto polyRGD (Fig. 2G-I).
We next analysed the effect of uncoupling ARAP3 from PI3K on neutrophil degranulation
by assaying gelatinase activity in supernatants of neutrophils that had or had not been
stimulated. Like ROS production, this can be triggered by soluble stimuli, or by ligation of
integrins. In-line with the results obtained with the ROS assays, Arap3PH*/PH* and control
neutrophils released very similar amounts of gelatinase granules on stimulation with a
Gambardella et al. Page 5
J Immunol. Author manuscript; available in PMC 2013 July 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
soluble agonist (fMLF in the presence of cytochalasin B), whilst granule release in the PH
domain point mutants was enhanced on being plated onto the integrin ligand fibrinogen in
the presence of TNFα (Fig. 2J,K).
We finally compared the ability of control and Arap3PH*/PH* neutrophils to adhere and
spread. Arap3PH*/PH* neutrophils plated onto polyRGD adhered and spread significantly
more than controls (Fig. 2L-N; we observed the same pattern with fibrinogen in the presence
of TNFα, not shown).
In summary, our results indicated that uncoupling ARAP3 from PI3K perturbed neutrophil
responses on β2 integrin ligation, giving results typical for increased outside-in signalling.
β2 integrin inside-out signalling is increased in Arap3PH*/PH* neutrophils
To address why integrin ligation caused these enhanced responses with Arap3PH*/PH*
neutrophils, we compared the major neutrophil β2 integrins, LFA1 and Mac1, of knock-in
and control neutrophils. Surface expression of Mac1 and LFA1 was not affected by the
presence of the PH domain point mutation (Fig. 3A).
Integrins are regulated by inside-out signalling (affinity and avidity modulation) (19). Since
we are not aware of any activation state-specific antibodies for murine β2 integrins, we
analysed ligand binding affinity experimentally. We tested the ability of neutrophils to bind
to ICAM1, a ligand for LFA1, in solution in the absence of any stimulation, using
quantitative immunofluorescence as a read-out. Arap3PH*/PH* cells were able to bind
significantly stronger to ICAM1 than wild-type controls (Fig. 3B), indicating that LFA1 on
Arap3PH*/PH* neutrophils was present in a higher affinity status than those on wild-type
cells.
We also microscopically analysed integrin lateral mobility (clustering), a read-out for
integrin avidity, in unstimulated cells that were kept in suspension. In confocal images of
unstimulated control cells, distribution of LFA1 and Mac1 resembled that of uniform beads
on a string (as did the neutrophil surface marker GR1, not shown). In contrast, Arap3PH*/PH*
neutrophils had a distinctively more clustered (patchy) LFA1 and Mac1 distribution (Fig.
3C). This suggested that the avidity of β2 integrins in Arap3PH*/PH* neutrophils was
increased compared to controls. In summary, whilst the surface expression of Mac1 and
LFA1 was unaltered by the PH domain point mutation in ARAP3, these integrins were
characterised by increased inside-out signalling in Arap3PH*/PH* neutrophils.
Immobilised immune complex-dependent events are upregulated in Arap3PH*/PH*
neutrophils
Immune complex binding induced cross-linking of FcγRs activates neutrophils, a function
important for autoimmune responses. We assayed ROS production after plating neutrophils
onto immobilised immune complexes, and found this to be significantly increased in
Arap3PH*/PH* cells (Fig. 4A,B). In-line with this observation, we also observed significantly
enhanced PKB and p38 phosphorylation, gelatinase granule release and cell spreading with
Arap3PH*/PH* neutrophils that had been plated onto immobilised immune complexes (Fig.
4C-J). Therefore, responses induced by immobilised immune complexes were perturbed in
Arap3PH*/PH* neutrophils.
FcγR signalling is not directly affected in Arap3R302,3A/R302,3A neutrophils
To address why Arap3PH*/PH* neutrophils displayed these perturbed responses on being
plated onto immobilised immune complexes, we analysed FcγR signalling further. We did
not detect significantly different surface expression of FcγRII/III or of FcγRIV between
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control and Arap3PH*/PH* neutrophils (Fig. 5A). Using specific blocking antibodies in ROS
assays with neutrophils plated onto immobilised immune complexes we found blocking
FcγRII/III caused a significant reduction in both wild-type and Arap3PH*/PH* neutrophils,
whilst blocking FcγRIV alone had very little effect. Using both blocking antibodies together
virtually abolished the ROS production in both control and Arap3PH*/PH* neutrophils (Fig.
5B), in agreement with published work (15), and confirmed that immune complex induced
ROS production was indeed FcγR dependent.
To test whether ARAP3 affected FcγR signalling directly, we stimulated cells in solution by
antibody-mediated FcγR cross-linking and measured ROS production. We observed very
similar ROS production by primed or unprimed Arap3PH*/PH* neutrophils compared to
controls on cross-linking FcγRII/III (Fig. 5C; we were unable to obtain meaningful results
on cross-linking FcγRIV in a similar manner). We also measured PKB and p38
phosphorylation on FcγRII/III cross-linking in solution. Again we observed very similar
activations in control and Arap3PH*/PH* neutrophils (Fig 5D). This work suggested, that the
presence of the PH domain mutation in ARAP3 did not affect signalling through FcγR per
se, but rather, that we had observed an indirect effect when assaying Arap3PH*/PH*
neutrophils that had been plated onto immobilised immune complexes.
Adhesion-dependent RhoA activation is increased in Arap3PH*/PH* neutrophils
ARAP3 is a functional GAP protein for RhoA and Arf6 that is activated by PI3K and Rap.
To analyse the mechanism underlying our observations, we carried out activity assays. Since
Rap is known to regulate integrins, we assayed Rap1-GTP in Arap3PH*/PH* neutrophils that
were kept in suspension or plated onto polyRGD. Rap1-GTP was significantly increased on
plating neutrophils of either genotype onto polyRGD, but we detected no significant
differences between genotypes in suspension cells or those plated onto polyRGD (Fig. 6A).
We next analysed Arf6-GTP in neutrophils that were kept in suspension or plated onto
polyRGD. Arf6 was strongly activated by plating control and Arap3PH*/PH* neutrophils onto
polyRGD. No difference was observed between the two genotypes (Fig. 6B). RhoA was also
significantly activated on plating control and Arap3PH*/PH* neutrophils onto polyRGD. Our
measurements indicated that RhoA fold activation was significantly higher in Arap3PH*/PH*
than in control neutrophils (Fig. 6C), suggesting that the incorporation of the PH* mutation
into ARAP3 affected RhoA signalling in neutrophils. Since RhoA and Rac are known to
cross-talk, we also analysed Rac. In agreement with previously published data from human
neutrophils (20), neither Rac1 nor Rac2 were activated in neutrophils by plating onto
polyRGD. We did not observe any differences in Rac1 and Rac2 activities between wild-
type control and Arap3PH*/PH* neutrophils (not shown). To summarise, RhoA signalling
was affected in Arap3PH*/PH* neutrophils plated onto integrin ligands, which is suggestive
of an involvement of RhoA signalling in the adhesion-dependent Arap3PH*/PH* phenotype
we observed.
We monitored phospho myosin light chain (pMLC), a RhoA effector, as an indirect read-out
for the localisation of RhoA activation in the neutrophils. In wild-type control cells F-actin
and pMLC staining were mutually exclusive. In contrast, pMLC localization was perturbed
in Arap3PH*/PH* neutrophils that had or had not been stimulated with fMLF (Fig 6D and not
shown), suggestive of mislocalized RhoA-GTP in these cells.
Arap3PH*/PH* neutrophils have a chemotaxis defect in vitro
To test whether uncoupling ARAP3 from PI3K affects the ability of neutrophils to
chemotax, we performed Dunn chamber chemotaxis assays. We assayed cells migrating
towards fMLF, a commonly used chemoattractant in this context, which has been shown to
support PI3K and p38 MAPK mediated chemotaxis. We also analyzed cells migrating
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towards MIP2, the murine equivalent of human IL-8, that has been shown to promote
chemotaxis independently of p38, in a PI3K-dependent fashion (21, 22). Tracking of cell
trajectories (Fig. 7A) followed by computational analysis of the tracks showed that
Arap3PH*/PH* neutrophils travelled longer total, but shorter euclidian distances exhibiting
reduced directionality compared to controls (Fig. 7B,C) when migrating towards fMLF.
When the cells moved towards MIP2 (Fig 7D-F), the defect observed was more severe, with
Arap3PH*/PH* neutrophils migrating shorter accumulated and euclidian distances than their
control counterparts whilst the directionality defect remained. These measurements
confirmed that uncoupling ARAP3 from PI3K caused an in vitro neutrophil chemotaxis
defect, the nature of which is dependent on the chemoattractant used and the signalling
intermediates it relies on.
Arap3PH*/PH* cells have a recruitment defect in vivo
To analyse in vivo chemotaxis, we assessed neutrophil recruitment to the peritoneum of
control and Arap3PH*/PH* bone marrow chimeras in which sterile peritonitis had been
induced by thioglycollate. In this assay, significantly reduced numbers of Arap3PH*/PH*
neutrophils were recruited to the peritoneum (Fig. 7G). In the lights of the elevated
responses of Arap3PH*/PH* neutrophils we had observed on plating neutrophils onto
immobilised immune complexes in vitro, we next tested the effect of uncoupling ARAP3
from PI3K in the context of a model of an autoimmune disease. For this we made use of the
well-characterised K/BxN serum transfer model for the effector phase of rheumatoid
arthritis (23, 24). In this model, arthritogenic K/BxN serum is transferred to healthy mice,
resulting in neutrophil-dependent inflammation of their joints. Sera were injected into
lethally irradiated recipient mice reconstituted with Arap3PH*/PH* or matched control bone
marrows, and ankle thickness and clinical score were measured over 14 days (Fig. 7H).
Unexpectedly, arthritogenic serum-injected Arap3PH*/PH* bone marrow chimeras were less
affected than control chimeras. Hence, Arap3PH*/PH* neutrophils conferred mild protection
from immunoarthritis. The inflammatory response in the K/BxN model depends on efficient
neutrophil recruitment to the joints. We analysed this in ankle sections from chimeras that
had been injected with control or arthritogenic serum, and observed reduced tissue
infiltration in joints from Arap3PH*/PH* chimeras (Fig 7I). This suggests, the protection from
arthritis in these animals was due to a leukocyte recruitment defect conferred by uncoupling
ARAP3 from activation by PI3K.
Discussion
We recently showed that ARAP3 is an important regulator of neutrophils, involved in the
modulation of integrin inside-out signalling, and regulating responses downstream of
integrin ligation. ARAP3 is regulated by the PI3K lipid product PtdIns(3,4,5)P3 and by Rap-
GTP. To analyse the regulatory contribution of PI3K on ARAP3 in the neutrophil, we
analysed neutrophils in which ARAP3 harboured a PH domain point mutation that
uncoupled it from activation by PI3K. The present work argues that ARAP3 is an important
PI3K effector in neutrophils.
We demonstrated before that ARAP3 is regulated by PI3K catalytically, and it is also
recruited to the plasma membrane in a PI3K and PH domain-dependent fashion. Therefore,
the regulatory role of PI3K upstream of ARAP3 could contain direct and/or indirect
components. PI3K has been shown to regulate integrins in several cell types (25-27) and our
present work argues that it does this in the neutrophil at least in part by signalling through
ARAP3. However, lack of PtdIns(3,4,5)P3 mediated recruitment of the ARAP3 PH domain
point mutant to the plasma membrane could also have impinged on ARAP3’s ability to be
regulated by Rap, an established regulator of integrin inside-out signalling (28-30). We are
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currently devising an ARAP3 Ras binding domain point mutation knock-in to address this
possibility.
Interestingly, we noted that PKB phosphorylation, a commonly used read-out of PI3K
activity, was increased in Arap3PH*/PH* neutrophils that had been plated onto polyRGD or
immobilised immune complexes (Figs 2 and 4). In contrast, Rap-GTP was not affected by
genotypes (Fig 6), suggesting that Rap is not involved in a feed-back loop involving ARAP3
and integrin signalling, whilst PI3K might be.
We carried out activity assays to elucidate the mechanism downstream of ARAP3 in this
complex phenotype. Plating neutrophils onto polyRGD caused activation of RhoA and Arf6,
but only RhoA fold-activation was increased in the knock-in cells, suggesting a regulatory
role for RhoA downstream of ARAP3. Indeed, RhoA has been shown in a variety of cell
types to regulate integrins (26, 31-34). Although RhoA and Rac have been shown to have an
antagonistic relationship in many experimental systems (35), cross-talk between Rho and
Rac does not appear to play a major role in this context. We noticed that the distribution of
pMLC was disturbed in Arap3PH*/PH* neutrophils, suggesting indirectly that their RhoA-
GTP localization may be affected. This will be investigated further in future work.
Potentially, perturbed distribution of RhoA-GTP could have contributed to the chemotaxis
defect we observed.
In our in vitro assays, immune complex induced responses were found to be increased in
Arap3PH*/PH* neutrophils in addition to integrin-dependent ones. Since activating cells by
cross-linking their FcγRII/III did not cause similarly increased responses, uncoupling
ARAP3 from activation through PI3K does not directly affect signalling through FcγRII/III.
We cannot exclude a potential direct effect on the activating FcγRIV (7), which acts
together with FcγRIII to regulate immobilised immune complex-dependent activation of
neutrophils (15), since we were unable to test this receptor experimentally in similar cross-
linking experiments. An alternative explanation for our data could be, that cross-talk
between β2 integrins and FcγRs takes place when FcγR-dependent signalling is induced by
immobilised immune complexes. The pre-activated β2 integrins of Arap3PH*/PH*
neutrophils might be able to modulate FcγR-dependent signalling. Cross-talk between
integrin and FcγR signalling has previously been described both in vitro (36-38) and with in
vivo models (39-41). Whilst the molecular mechanisms of such cross-talk has yet to be
elucidated, it has been clearly demonstrated that both classes of receptors share common
downstream signalling adaptors and further components of their signalling cascades (42).
We observed a chemotaxis defect with Arap3PH*/PH* neutrophils in vitro, which was more
pronounced when MIP2 rather than fMLF was used as a chemoattractant, in-line with the
distinct dependency on PI3K by these two chemoattractants (21, 22). We also noted
evidence for recruitment defects to the peritoneum and joints, respectively, on inducing
sterile inflammation in these locations. Neutrophil recruitment to the periphery is known to
depend on β2 integrins (43), and our data suggests that PI3K-dependent, ARAP3-mediated
fine tuning of β2 integrin inside-out signalling is required for such recruitment to occur in an
efficient manner. Interestingly, our result are in-line with findings from several other
laboratories who reported that constitutively activating β2 integrins (Mac1 or LFA1) either
genetically by introducing activating mutations or pharmacologically by employing specific
small molecule agonists results in reduced leukocyte extravasation, reduced neutrophil
recruitment in sterile peritonitis and reduced inflammation in a number of animal model
systems (44, 45).
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Figure 1. Incorporating a PH domain point mutation does not affect ARAP3 expression
(A) Protein from 1×106 bone marrow derived neutrophils from control (Arap3+/+),
heterozygous (Arap3+/PH*) or homozygous mutant (Arap3PH*/PH*) mice was immunoblotted
for ARAP3 (top panel) or β-COP (bottom panel) as a loading control. Representative
experiment shown from four independent experiments. (B) Peripheral blood cells from bone
marrow chimeras reconstituted with Arap3PH*/PH* (PH*) or matched control (WT)
hematopoietic stem cells were analysed using a Vet ABC animal blood cell counter. Data
shown (means ±SEM) were obtained with 14 wild-type and 12 knock-in chimeras generated
with three individual bone marrow donors per genotype.
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Figure 2. Integrin-dependent events are upregulated in Arap3PH*/PH* neutrophils
(A-F) Bone marrow-derived Arap3PH*/PH* (PH*) and matched wild-type control (WT)
neutrophils were prepared, primed with TNFα and GM-CSF or mock primed (A,D) and (all)
pre-incubated with luminol as described in materials and methods. 5×105 cells were plated
into 96 well plates containing fMLF as a soluble stimulus (A,D) or that had been coated with
fibrinogen (B,E) or polyRGD (C,F). Light emission was measured in a Berthold
Microluminat Plus luminometer. Data were recorded in duplicate. Data (means ± range)
from a representative experiment are shown in panels A-C whilst panels D-F represent
accumulated light emissions (means ± SEM) from four separate, pooled experiments
expressed as a percentage of the responses obtained with control neutrophils. (G-I)
Neutrophils were allowed to adhere to heat inactivated serum-blocked (hiFCS) or polyRGD-
coated plastic. Lysates were prepared and immunoblotted with antibodies specific for
phospho-PKB (Ser 473) or phospho-p38 (T180, Y182) or β-COP as a loading control. A
representative example is shown (G). Blots were quantitated using ImageJ software;
integrated data obtained from five independent experiments are shown (H,I). (J,K)
Gelatinase granule release was measured by zymography of supernatants of neutrophils that
were allowed to adhere to hiFCS-blocked or fibrinogen-coated dishes. As a control,
neutrophils were stimulated with fMLF in the presence of cytochalasin B (CB). A
representative experiment is shown (J; the samples were run on two separate gels and are
pasted next to one another for ease of viewing here, this is indicated by a dotted line).
Integrated, quantitated data obtained from four independent experiments are plotted (K). (L-
N) Neutrophils were allowed to adhere to pRGD-coated tissue culture dishes, washed and
fixed. Numbers of attached cells (phase dark) per field of view, and the percentage of spread
cells (phase light) were counted. Integrated data obtained from three separate experiments
(L,M) and representative examples (N) are shown. (All) Raw data were analysed by T-test
(Mann Whitney); * p<0.05; ** p<0.01; ***p<0.001.
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Figure 3. β2 integrins on Arap3PH*/PH*neutrophils have higher affinity and avidity
(A) Wild-type control and Arap3PH*/PH* bone marrow cells were or were not pre-incubated
with 20ng/ml TNFα at 37°C before being labelled with PE-conjugated anti GR1, APC-
conjugated anti Mac1 and FITC-conjugated anti LFA1. For FACS analysis, GR1-positive
cells were gated and Mac1 and LFA1 staining was measured. Results were analysed with
FlowJo V6.4.7 software. Cells from 15 knock-in and 11 control chimeras obtained from
three separate reconstitutions were analysed in three experiments.
Representative traces are shown. black lines, wild-type; grey lines, Arap3PH*/PH* ; broken
lines, no TNFα, full lines, with TNFα. (B) Unstimulated, bone marrow derived control
(WT) and Arap3PH*/PH* (PH*) neutrophils were allowed to bind to ICAM1-Fc in solution in
the absence of any stimulation. Cells were washed, fixed and bound ICAM1 was stained
with a fluorescently conjugated secondary antibody. Washed, stained cells were allowed to
settle on electrostatically coated slides and signal strength was measured by quantitative
immunofluorescence. Mean fluorescence intensity obtained from 64 knock-in and 50 control
cells in three independent experiments is plotted (mean ± SEM) and representative examples
are shown. (C) Integrin clustering was analysed in unstimulated control and Arap3PH*/PH*
neutrophils in solution. Bone marrow derived neutrophils were prepared and incubated at
37C in the presence of anti LFA1 or anti Mac1, washed, fixed, stained with a fluorescently
conjugated secondary antibody and allowed to settle on electrostatically labelled slides.
Distribution of fluorescence was assessed by confocal microscopy. Representative examples
(stained for LFA1) are shown together with their corresponding heatmaps (obtained by
analysis with ImageJ). Pooled results stem from four independent experiments, in each of
which 25 cells per genotype were analysed are plotted (mean ± SEM). (B,C). Results
obtained were analyed by paired T-tests. * p<0.05; ** p<0.01.
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Figure 4. Immune complex-induced events are upregulated in Arap3PH*/PH* neutrophils
(A,B) Bone marrow-derived Arap3PH*/PH* (PH*) and matched wild-type control (WT)
neutrophils were prepared and pre-incubated with luminol as described in materials and
methods. 5×105 cells were plated into 96 well plates that had been coated with an immune-
complex (BSA anti-BSA). Light emission was measured in a Berthold Microluminat Plus
luminometer. Data were recorded in duplicate. Data (means ± range) from a representative
experiment are shown in panel A whilst panel B represents accumulated light emissions
(means ± SEM) from four independent experiments expressed as a percentage of the
responses obtained with wild-type control neutrophils. (C-E) Neutrophils were allowed to
adhere to heat inactivated BSA-blocked (BSA) or immune complex-coated (BSA-αBSA)
plastic. Lysates were prepared and subjected to immunoblotting with antibodies specific for
phospho-PKB (Ser 473) or phospho-p38 (T180, Y182) or β-COP as a loading control. A
representative example is shown (C). Blots were quantitated using ImageJ software;
integrated data obtained from five independent experiments are shown (D,E). (F,G)
Gelatinase granule release was measured by zymography of supernatants of neutrophils that
were allowed to adhere to BSA-blocked or immune complex-coated dishes. A representative
experiment is shown (F; the samples were not in this order on the original gel and have been
pasted next to one another for ease of viewing, this is indicated by a dotted line). Integrated,
quantified data obtained from four independent experiments are plotted (G). (H-J)
Neutrophils were allowed to adhere to immune complex-coated tissue culture dishes,
washed and fixed. Numbers of attached cells (phase dark) per field of view, and the
percentage of spread cells (phase light) were counted. Integrated data obtained from three
separate experiments are plotted (I,J) and representative examples are shown (H). (All) Raw
data were analysed by T-test (Mann Whitney). * p<0.05; ** p<0.01; ***p<0.001.
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Figure 5. FcγR are not affected in Arap3PH*/PH* neutrophils
(A) Surface distribution of FcγRII/III and FcγRIV was analysed by FACS analysis of bone
marrow cell populations. Seven wild-type and seven knock-in chimeras obtained from three
different pairs of donors were analysed in two independent experiments. A representative
example is shown. Black lines represent control cells and grey lines Arap3PH*/PH*. FcγRII/
III FACS: broken lines represent unstimulated and full lines TNFα-stimulated samples;
FcγRIV FACS: dotted lines represent isotype control. (B) Immune complex induced ROS
formation depends on signalling through FcγRs. Neutrophils were or were not pre-
incubating with FcγR blocking antibodies and/or isotype controls as indicated, before being
plated onto immobilised immune complexes for ROS assays. Pooled results from three
independent experiments are plotted (mean ± SEM). Differences between wild-type and
Arap3PH*/PH* were highly significant (p<0.001) for all conditions except anti-FcγRII/III +
anti-FcγRIV (p>0.05), two-way ANOVA with Bonferroni post-test. (C) Cross-linking
FcγRII/III does not cause increased ROS production in Arap3PH*/PH* neutrophils. Bone
marrow derived neutrophils were prepared from control and knock-in mice and incubated
with anti FcγRII/III with or without priming. After washing, ROS production was measured
on cross-linking the FcγR with a F(ab’)2 fragment. A representative example is shown (left)
and integrated results from five independent experiments are plotted (mean ± SEM).
Differences did not reach statistical significance (p>0.1; Mann Whitney T-test). (D) Control
and Arap3PH*/PH* neutrophils were incubated with FcγRII/III antibody, washed, and
stimulated by F(ab’)2 fragment-mediated cross-linking for the indicated amounts of time.
Time 0, no cross-linking. Lysates were prepared and protein subjected to immunoblotting.
PKB and p38 phosphorylation was analysed using phospho-specific antibodies; β-COP
served as loading control. A representative experiment from four independent experiments is
shown.
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Figure 6. RhoA activation is affected in Arap3PH*/PH* neutrophils
(A-C) Wild-type control (WT) and Arap3PH*/PH* (PH*) neutrophils were kept in suspension
or plated onto polyRGD-coated tissue culture plastic. Cells were lysed with ice-cold lysis
buffer. (A, B) Clarified lysates were subjected to ‘pull-down’ assays using GST-Ral GDS as
bait to determine GTP-loaded fractions of Rap (A) and using GST-MT2 bait to determine
GTP-loaded Arf6 (B). Results obtained from a minimum of five independent experiments
were pooled and plotted (mean ± SEM, left); representative examples are shown (right). L,
lysates, PD, pull-downs. Blots were probed with an antibody specific for Rap1 (A) and Arf6
(B). (C) Clarified lysates were employed in RhoA G-LISA assays to determine GTP-loaded
RhoA. Results from five pooled, independent experiments are presented (mean ± SEM). (A-
C) Raw data were analysed by paired T-tests. * p<0.05; ** p<0.001. (D) Indirect assessment
of localisation of RhoA activation. Neutrophils were or were not stimulated for the indicated
time with 1μM fMLF in solution, allowed to settle on a glass coverslip for 3 minutes, fixed
and stained using phalloidin, to visualise filamentous actin and anti phospho myosin light
chain. Representative cells from three independent experiments are shown.
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Figure 7. Arap3PH*/PH* neutrophils have a chemotaxis defect
(A-F) In vitro chemotaxis assays. Bone marrow derived Arap3PH*/PH* and control
neutrophils were allowed to chemotax towards 300nM fMLF (A-C) or towards 10nM MIP2
(D-F) in Dunn chambers. Movements were recorded by time-lapse imaging. (A,D) Pooled
tracks of individual cells from experiments carried out with three separate cell preparations
were plotted using the Ibidi chemotaxis tool plug-in into ImageJ. The source of
chemoattractant is at the below. The tracks were analysed using the Ibidi chemotaxis tool’s
statistics features. Accumulated and Euclidian distances and directionality are plotted (mean
± SEM; B,C; E,F). (G) Neutrophil recruitment to the peritoneum in a model for sterile
peritonitis. Bone marrow chimeras (generated with four bone marrow donors per genotype)
were intraperitoneally injected with 0.25ml thioglycollate containing broth. Mice were
sacrificed 4.5 hours after injection, their peritonea were flushed and Mac1high GR1-positive
neutrophils were counted. Pooled results obtained from two separate experiments are
plotted. (B-G) Data were analysed by T-tests (Mann Whitney). * p<0.05; *** p<0.001. (H-I)
Serum transfer arthritis. Twelve wild-type and 13 Arap3PH*/PH* bone marrow chimeras
were injected with 150μl arthritic serum and six wild-type and six Arap3PH*/PH* bone
marrow chimeras were injected with 150μl control serum in two separate experiments.
Joints were scored daily for two weeks. Ankle thickness and clinical score are plotted.
Circles, and dotted lines, wild-type bone marrow chimeras; triangles and full lines,
Arap3PH*/PH* bone marrow chimeras. Blue symbols, control serum; red symbols,
arthritogenic serum. The area under the graph was compared by T-test (Mann Whitney);
ankle thickness, p=0.053; clinical score, p=0.023. (I) Wax sections of decalcified joints from
chimeras reconstituted with control (WT) or Arap3PH*/PH* (PH*) bone marrows induced as
indicated were H&E stained to visualise leukocyte infiltration on day 4 after serum
injection. Representative examples from sections obtained with 6 arthritogenic and 2 control
serum-injected mice mice in two independent experiments are shown.
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Table I
Litters from Arap3R302,3A intercrosses
Total Arap3 +/+ Arap3+/R302,3A Arap3R302,3A/R302,3A
Arap3+/R302,3A x
Arap3R302,3A/R302,3A
90 - 80 10
Arap3+/R302,3A x
Arap3+/R302,3A
264 85 174 5
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